Literature DB >> 15847842

Therapeutic management of brain metastasis.

Evert C A Kaal1, Charles G J H Niël, Charles J Vecht.   

Abstract

This review focuses on the management of brain metastases. The four main modes of therapy are discussed: whole brain radiation therapy (WBRT), surgery, radiosurgery, and chemotherapy. Young patients with limited extracranial disease may benefit from surgical resection of a single brain metastasis, and from radiosurgery (or stereotactic radiotherapy) if two to four brain metastases are present. Whether WBRT after surgery or radiosurgery is beneficial is uncertain. Therefore, two approaches can be justified in patients with a good prognosis: WBRT after surgery or radiosurgery, or alternatively, observation with MRI follow-up after surgery or radiosurgery. A hyperfractionated radiation scheme is then to be preferred to limit late toxicity of WBRT. Patients with extensive extracranial tumour activity or impaired quality of life may benefit from radiosurgery (one to four brain metastases), or from shorter WBRT schedules. We propose a decision tree on the various ways to treat brain metastasis.

Entities:  

Mesh:

Year:  2005        PMID: 15847842     DOI: 10.1016/S1474-4422(05)70072-7

Source DB:  PubMed          Journal:  Lancet Neurol        ISSN: 1474-4422            Impact factor:   44.182


  53 in total

1.  Contrast-enhanced MR imaging of brain lesions: a large-scale intraindividual crossover comparison of gadobenate dimeglumine versus gadodiamide.

Authors:  H A Rowley; G Scialfa; P-y Gao; J A Maldjian; D Hassell; M J Kuhn; F J Wippold; M Gallucci; B C Bowen; I M Schmalfuss; J Ruscalleda; S Bastianello; C Colosimo
Journal:  AJNR Am J Neuroradiol       Date:  2008-07-03       Impact factor: 3.825

2.  Focal radiation therapy of brain metastases after complete surgical resection.

Authors:  Gautam Bahl; Greg White; John Alksne; Lakshmi Vemuri; Matthew A Spear
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  Expression of endoplasmic reticulum stress proteins is a candidate marker of brain metastasis in both ErbB-2+ and ErbB-2- primary breast tumors.

Authors:  Rebeca Sanz-Pamplona; Ramón Aragüés; Keltouma Driouch; Berta Martín; Baldo Oliva; Miguel Gil; Susana Boluda; Pedro L Fernández; Antonio Martínez; Víctor Moreno; Juan J Acebes; Rosette Lidereau; Fabien Reyal; Marc J Van de Vijver; Angels Sierra
Journal:  Am J Pathol       Date:  2011-06-25       Impact factor: 4.307

4.  Radiomics as prognostic factor in brain metastases treated with Gamma Knife radiosurgery.

Authors:  Chih-Ying Huang; Cheng-Chia Lee; Huai-Che Yang; Chung-Jung Lin; Hsiu-Mei Wu; Wen-Yuh Chung; Cheng-Ying Shiau; Wan-Yuo Guo; David Hung-Chi Pan; Syu-Jyun Peng
Journal:  J Neurooncol       Date:  2020-02-04       Impact factor: 4.130

5.  Factors influencing the outcome of stereotactic radiosurgery in patients with five or more brain metastases.

Authors:  E Hamel-Perreault; D Mathieu; L Masson-Cote
Journal:  Curr Oncol       Date:  2019-02-01       Impact factor: 3.677

6.  Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.

Authors:  Esther J J Habets; Linda Dirven; Ruud G Wiggenraad; Antoinette Verbeek-de Kanter; Geert J Lycklama À Nijeholt; Hanneke Zwinkels; Martin Klein; Martin J B Taphoorn
Journal:  Neuro Oncol       Date:  2015-09-18       Impact factor: 12.300

7.  Estimating the annual frequency of synchronous brain metastasis in the United States 2010-2013: a population-based study.

Authors:  Courtney Kromer; Jordan Xu; Quinn T Ostrom; Haley Gittleman; Carol Kruchko; Raymond Sawaya; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2017-05-31       Impact factor: 4.130

Review 8.  Treatment of Brain Metastases.

Authors:  Xuling Lin; Lisa M DeAngelis
Journal:  J Clin Oncol       Date:  2015-08-17       Impact factor: 44.544

9.  Prognosis of non-small cell lung cancer with synchronous brain metastases treated with gamma knife radiosurgery.

Authors:  Doo-Sik Kong; Jung-Il Lee; Do-Hyun Nam; Kwan Park; Jong Hyun Kim; Jhin Gook Kim; Jun-O Park; Keunchil Park
Journal:  J Korean Med Sci       Date:  2006-06       Impact factor: 2.153

10.  Antiepileptics in brain metastases: safety, efficacy and impact on life expectancy.

Authors:  M Maschio; L Dinapoli; S Gomellini; V Ferraresi; F Sperati; A Vidiri; P Muti; B Jandolo
Journal:  J Neurooncol       Date:  2009-11-24       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.